Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Merck cholesterol drug’s odds dim after Lilly failure

The odds that Merck & Co’s high-stakes cholesterol drug will succeed have dropped dramatically after Eli Lilly and Co said its similar medicine failed to reduce heart attacks and strokes, top U.S. heart doctors said. Lilly on Monday said it was halting a 12,000-patient study of its drug, evacetrapib, an oral medication. In earlier studies, […]

Read More »

Reforms needed to address medical diagnostic errors: U.S. report

Most Americans will fall victim to at least one diagnostic error in their lifetime, and when this occurs, it often can be deadly, according to a new report released on Tuesday by the Institute of Medicine, which advises the U.S. government and policymakers. The report called for greater emphasis on improving diagnoses in the United […]

Read More »

For First Time, America’s Uninsured Rate Is Below 10% – And It’s Because Of Obamacare

For the first time in more than 50 years of surveys, the CDC on Wednesday reported that more than 90% of Americans — 90.8% of us, to be specific — have health insurance. Until now, no major survey had ever found that the uninsured rate in America has hit single digits. The data comes from the National […]

Read More »

Patient Adherence – Special Feature

Still no Rx for patient adherence Pharma limited in what it can do, but can still have a positive impact   Patient adherence remains a complex puzzle with no simple solutions, and no one stakeholder involved – physicians, insurers, or pharmaceutical companies – can provide all the answers needed. Even though the influence of pharma […]

Read More »

The mandate for healthcare consumer activation

By Omar Shoheiber and Neil Goldfarb — Omar Shoheiber is managing partner of Guidemark Health. Neil Goldfarb is executive director of the Greater Philadelphia Business Coalition on Health.   The U.S. healthcare system is changing dramatically, and the magnitude and speed of change in healthcare delivery and financing have been overwhelming to all system stakeholders. […]

Read More »

Google Is Now Alphabet, And That Could Spell Big Things For Health Care

If you’re searching for reasons why Google has renamed itself Alphabet, here’s one: It positions the tech company to expand into health care, which could be very healthy for its long-term fortunes. Google’s health care ambitions are no secret. In the past year alone, the company has teased a pill that would detect cancer, debuted […]

Read More »

Pharmacy benefit manager CVS urges rewrite for U.S. heart guidelines

CVS Health Corp, the second-largest manager of drug benefit plans for U.S. employers and insurers, asked heart specialists on Monday to revamp guidelines for treating patients with high cholesterol after the launch of new, expensive medications. The unusual move is the latest salvo in the war on escalating U.S. healthcare costs, with insurers using aggressive […]

Read More »

China’s much-hyped healthcare reform drive stuck in first gear

Li Tiantian, a Chinese doctor turned tech entrepreneur, is a leading light of the country’s much-trumpeted healthcare reform drive. His medical networking platform links two million doctors across China and has attracted funding from tech giants like Tencent. DXY is exactly what Beijing has said it’s looking to support after it pinpointed remote healthcare, […]

Read More »

New Report Shows Majority of States Missing Opportunities to Reduce Toll of Cancer

WASHINGTON, Aug. 6, 2015 /PRNewswire-USNewswire/ — A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a report released today by the American Cancer Society Cancer Action Network (ACS CAN). “How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality” […]

Read More »

Birth Control Pills Give Women Dramatic Anti-Cancer Benefits

Women now have a surprising new reason to go on the pill. Birth control pills have been around since the 1960s, when they offered women a revolutionary degree of control over their reproductive capabilities. Over the years, the formulation of “the pill” has changed, but it remains one of the most widely used, and most […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom